US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Acast AB (0A9Z) 銘柄情報

Acast AB (0A9Z)

0.00

0.00

(0.00%)

終了 7月12日 12:30AM

Acast AB (0A9Z) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

-

( - )

買値

0.00

売値

0.00

出来高

0.00

平均取引量 (3 か月)

SEK 398,562

財務取引量

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

企業価値

6.762B

前日終値

0.00

始値

-

時刻

最終取引時間

VWAP

-

歳入

2.63B

純利益

-2.77M

発行済株式数

182,465,260

浮動株比率 (%)

59.03%

機関投資家保有比率 (%)

61.52%

配当利回り

PER

-2.61k

株価売上高倍率 (PSR)

2.75

1 株当たり利益 (EPS)

-0.01

ベータ

0.41

Acast AB (publ) operates as a podcasting company in Europe, North America, and internationally. It provides podcast marketplace and building technology to connect podcast creators, advertisers, and listeners. The company also operates a podcast platform to host and distribute their podcast. In addit... Acast AB (publ) operates as a podcasting company in Europe, North America, and internationally. It provides podcast marketplace and building technology to connect podcast creators, advertisers, and listeners. The company also operates a podcast platform to host and distribute their podcast. In addition, it offers podcast advertising services for promotion of the brand; and monetization opportunities for podcast creators and advertisers. Acast AB (publ) was incorporated in 2013 and is headquartered in Stockholm, Sweden. 詳細を表示

セクター

Communication Services

業界

Interactive Media & Services

ウェブサイト

www.acast.com

本社

Stockholm, Sweden

設立

2026

Acast AB is listed in the Communication Services sector of the ロンドン証券取引所 with ticker 0A9Z. The last closing price for Acast AB was SEK0. Over the last year, Acast AB shares have traded in a share price range of SEK 0.00 to SEK 0.00.

Acast AB currently has 182,465,260 shares in issue. Acast AB has a price to earnings ratio (PE ratio) of -2,607.52.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

0A9Z - Frequently Asked Questions (FAQ)

What is the current Acast AB share price?

The current share price of Acast AB is SEK 0.00

How many Acast AB shares are in issue?

Acast AB has 182,465,260 shares in issue

What is the 1 year trading range for Acast AB share price?

Acast AB has traded in the range of SEK 0.00 to SEK 0.00 during the past year

What is the PE ratio of Acast AB?

The price to earnings ratio of Acast AB is -2.61k

What is the cash to sales ratio of Acast AB?

The cash to sales ratio of Acast AB is 2.75

What is the registered address of Acast AB?

The registered address for Acast AB is Kungsgatan 28, Stockholm, Stockholm County, 111 35

What is the Acast AB website address?

The website address for Acast AB is www.acast.com

Which industry sector does Acast AB operate in?

Acast AB operates in the Interactive Media & Services sector

NotTheRealBeeny

NotTheRealBeeny 6分前

Wouldn't it be perfect if Applbaum drafted the NDAs?
🤣

FrostyIsland3

FrostyIsland3 8分前

Baxer, I gather that you are saying that the CHM issued a CHM Letter to NWBO regarding DCVax-L shortly after the November 2025 CHM meeting and NWBO is going through the procedures described in Section 2.6 of the MHRA guidance. Why do you think the CHM issued a CHM Letter instead of issuing a 2nd RF

DayofReckoning

DayofReckoning 10分前

$TWOH what’s your point?

DayofReckoning

DayofReckoning 11分前

You have to own $TWOH shares to care .. thanks for the insight
Good luck to ya

gitreal

gitreal 11分前

Nobody will ever see a nickel back out of this scam. Sorry, the money's gone......and there's no platinum (gold, silver, etc ). Never was.

gitreal

gitreal 13分前

Hopefully some of those enablers will be named in the SEC complaint when it comes down. They're complicit in this, responsible for millions in investor losses. Benny will be named for sure.

FrostyIsland3

FrostyIsland3 19分前

FormalMHRAConsultant, Section 2.4 of the MHRA regulatory guidance enables the CHM to do one of 3 actions: 1. recommend approval of a new medicine to MHRA; 2. issue a 2nd RFI if there are still problems that prevent recommendation of approval but the CHM anticipates these problems can be overcome; a

jhdf51

jhdf51 19分前

Everyone has missed to be fair. But yes, using AI in this scenario? Waste of time.

JHD

Major Profits

Major Profits 22分前

"Remains to be seen if divys will actually be issued and if restricted or not. First divy in January and still not issued."
Just a guess, but I think they WILL be issued (at least the NEW ones). Restricted. The question, then, will be will they ever become UNrestricted and tradable? 🤷

OMOLIVES

OMOLIVES 23分前

They are on overtime currently. As they should be. Also, it was a complicated agreement between the officers of both Companies. That being Brian Foote:

https://investorshub.advfn.com/uimage/uploads/2026/7/11/[lyyeScreenshot_from_2026-07-11_22-52-20.png
https://investorshub.a

FrostyIsland3

FrostyIsland3 26分前

Is LC's allegation that management has not invested at least $50,000 of their own money in NWBO shares true?

Tr8dervic

Tr8dervic 27分前

Mega Million numbers for 07/10/2026 are:

02 39 44 46 56 Mega Ball 23

There was no Jackpot Winner

The estimated Jackpot was $604.0 Million ( $266.3 Million cash).

The next drawing is on Tuesday, Jul 14, 2026 with an estimated Jackpot of

nowwhat2

nowwhat2 30分前

Only the experts know ;
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177776692

https://investorshub.advfn.com/uimage/uploads/2026/7/11/uvvndgutsi_foundational_future.jpg

Make It Jake

Make It Jake 35分前

Current AIM-CASH weekly values – Large-caps decreased; mid-caps and small-caps increased.

Large- and mega-cap stocks : 60.9%
Much like last week, weeks nearest the current value had below-average returns and win rates in the shorter holding periods trending tow

FrostyIsland3

FrostyIsland3 35分前

Blackpool, NWBO is required to disclose the existence of a CHM Letter to investors because it is clearly material information. However, I think Baxers is right that Linda Powers and NWBO would intentionally not report the existence of a CHM Letter because there is no U.S. securities law case that e

fdicr

blah blah blah ... What are you talking about????? Are you sure you are on the right board. THis is FNMA board. do you have anything to say about FNMA?

j e d

Do you still think MHRA got the new analyses around March? And, about how long do you think they need to look at it before making a decision? Thank you.

Luis Andros

Luis Andros 46分前

10 career posts. All 10 saying the exact same thing. 🤭

oceans11

oceans11 48分前

What’s your take home on that?Or is that your weekly gross?

FrostyIsland3

FrostyIsland3 51分前

Linda Powers and NWBO intentionally did not disclose the existence of a CHM Letter to investors i Baxers is correct. Further, Linda Powers acted very upbeat at the 12/29/2025 shareholders' meeting. This would be calculated deception because the shareholders' meeting would have occurred on the same

lakers17

lakers17 51分前

As always with this company, just like NSAV did and everything has been vague. If anyone thinks that 13 billion is real revenue not crypto they created or valued as revenue, I have a bridge for sale. Slimy reporting and accounting. Not audited. Remains to be seen if divys will actually be issue

NebraskaOTC

NebraskaOTC 55分前

LOL!!!! The $FITY excuses here are so great!! The amount of people pretending they are shocked by the selloff of this SCAM is hilarious.
This is great! This is awesome!! LOL!!!
Noooo, this is a SCAM. The selloff of $FITY was coordinated by the usual suspects. 🧌 MY PRECIO

AngeloFoca

AngeloFoca 1時間前

I changed my mind about a documentary on the trials and tribulations of NWBO's dealings in getting DC-Vax L approved.

No... No... nothing less than a 10 part series will do this saga justice.

We'll call it... "Game of Groans"

.

Twiggs333

Twiggs333 1時間前

By modernizing FDA oversight of distributed manufacturing, the proposal has the potential to reduce operational and manufacturing risk for companies developing advanced therapies. More importantly, it supports the transition from clinical-scale production to commercial-scale manufacturing. Instead o

Franklin Templeton ICAV

Treehouse Foods

Fundo De Investimento Im...

Ac Barr Nts Lkd S&p 500 ...

Nippon BS Broadcasting (PK)

International Power (EM)

SilverCrest Mines

International bond 1.25%...

DB Crude Oil Long ETN du... (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。